Shattuck Labs (NASDAQ:STTK – Get Free Report) will likely be releasing its earnings data before the market opens on Thursday, March 6th. Analysts expect Shattuck Labs to post earnings of ($0.38) per share and revenue of $1.00 million for the quarter.
Shattuck Labs Trading Down 24.6 %
STTK opened at $1.44 on Thursday. The company has a 50 day moving average of $1.23 and a 200 day moving average of $1.82. The company has a market cap of $68.75 million, a PE ratio of -0.94 and a beta of 1.70. Shattuck Labs has a 12 month low of $0.94 and a 12 month high of $11.76.
Wall Street Analyst Weigh In
Several research firms recently commented on STTK. HC Wainwright reaffirmed a “neutral” rating on shares of Shattuck Labs in a report on Friday, November 15th. Needham & Company LLC reissued a “hold” rating on shares of Shattuck Labs in a report on Thursday, November 14th. Four investment analysts have rated the stock with a hold rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $8.67.
Insider Buying and Selling at Shattuck Labs
In related news, Director Redmile Group, Llc acquired 133,371 shares of the stock in a transaction dated Wednesday, December 4th. The shares were purchased at an average price of $1.25 per share, for a total transaction of $166,713.75. Following the transaction, the director now owns 5,539,724 shares in the company, valued at $6,924,655. This represents a 2.47 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 10.50% of the company’s stock.
Shattuck Labs Company Profile
Shattuck Labs, Inc, a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers.
Read More
- Five stocks we like better than Shattuck Labs
- Where Do I Find 52-Week Highs and Lows?
- Buffett’s on the Sidelines – Should You Follow?
- Best Stocks Under $10.00
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Transportation Stocks Investing
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Shattuck Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shattuck Labs and related companies with MarketBeat.com's FREE daily email newsletter.
